Defunct Company
Total Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
2,088
NCT00411606
Normal Values of Facial Thermography
Phase: N/A
Role: Collaborator
Start: Dec 31, 2006
Completion: Jul 31, 2008
NCT00599872
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
Phase: Phase 3
Role: Lead Sponsor
Start: Mar 31, 2008
Completion: Dec 31, 2008
NCT00732654
The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy
Phase: Phase 1/2
Start: Aug 31, 2008
Completion: Jun 30, 2012
NCT01353079
Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy
Start: Apr 30, 2011
Completion: Apr 30, 2012
NCT05138523
Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)
Start: Nov 21, 2019
Completion: Jun 22, 2021
NCT05601180
Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID.
Start: Oct 27, 2022
Completion: Jan 15, 2024
NCT06184204
Observational Study:Safety,Efficacy and Quality of Life of Patients With Atrial Fibrillation, Treated With Trombix®
Start: Dec 18, 2023
Completion: Jun 22, 2025